Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

By afschroeder • November 23, 2025

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies. ACS Nano. 2025 Nov 22. doi: 10.1021/acsnano.5c14753. Epub ahead of print. PMID: 41273281.

Tags: General Internal Medicine, immune adjuvant nanocarrier, immune tolerance, immunotherapy, lipid nanoparticle, mRNA, Nano Medicine, Pancreatic ductal adenocarcinoma (PDAC), Post Doc, Publications, reprogramming, tumor microenvironment

Effects Of Medicare Advantage On Health Care Use And Outcomes Among Retired State Employees In 5 States

Huckfeldt PJ, Boese T, Shier V, Escarce JJ, Parsons HM, Sood N. Effects Of Medicare Advantage On Health Care Use And Outcomes Among Retired State[...]

Racial Differences in the Association Between School Quality and Adult Health: A Nationally Representative Longitudinal Study

Meza BPL, Hoang K, Biely C, Jackson N, Leifheit KM, Barnert E, Schickedanz A, Khidir H, Iyer S, Slavich GM, Guerrero AD, Dudovitz RN. Racial[...]

Implications of High Prevalence of Social Risks in a Veteran Population: The Importance of Actionable Social Risk Screening

Orji WU, Smith PD, Elmore JG. Implications of High Prevalence of Social Risks in a Veteran Population: The Importance of Actionable Social Risk Screening. J[...]